NuCana CMO discloses option and share holdings
NuCana plc Chief Medical Officer Jeffrey D. Bloss filed a Form 3 reporting his existing ownership in the company.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
NuCana plc Chief Medical Officer Jeffrey D. Bloss filed a Form 3 reporting his existing ownership in the company. The filing lists multiple option awards over Ordinary Shares with exercise prices between 0.0004 and 0.004 Pounds Sterling, including grants that are fully vested and others that vest between June 2026 and January 2027, subject to continued service. Bloss also reports direct ownership of 47,136 Ordinary Shares.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
Bloss Jeffrey D.
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Options | -- | -- | -- |
| Holding | Options | -- | -- | -- |
| Holding | Options | -- | -- | -- |
| Holding | Options | -- | -- | -- |
| Holding | Options | -- | -- | -- |
| Holding | Options | -- | -- | -- |
| Holding | Ordinary Shares | -- | -- | -- |
Holdings:
Options — 643,801,784 contracts (Direct);
Ordinary Shares — 47,136 shares (Direct)
Footnotes (6)
- F1. The ordinary shares, nominal value 0.0004 Pounds Sterling per share (the "Ordinary Shares"), of NuCana plc (the "Company") underlying this option have an exercise price of 0.004 Pounds Sterling, completed vesting on June 20, 2025 and expire June 20, 2035.
- F2. The Ordinary Shares underlying this option have an exercise price of 0.0005 Pounds Sterling, completed vesting on January 14, 2026 and expire January 14, 2036.
- F3. The Ordinary Shares underlying this option have an exercise price of 0.0004 Pounds Sterling and will vest as to 25% on June 20, 2026, with the remainder vesting in three equal annual installments thereafter, subject to the Reporting Person's continued service with the Company through the applicable vesting date.
- F4. The Ordinary Shares underlying this option have an exercise price of 0.004 Pounds Sterling and will vest as to 25% on June 20, 2026, with the remainder vesting in three equal annual installments thereafter, subject to the Reporting Person's continued service with the Company through the applicable vesting date.
- F5. The Ordinary Shares underlying this option have an exercise price of 0.0005 Pounds Sterling and will vest as to 25% on January 14, 2027, with the remainder vesting in three equal annual installments thereafter, subject to the Reporting Person's continued service with the Company through the applicable vesting date.
- F6. The Ordinary Shares underlying this option have an exercise price of 0.0004 Pounds Sterling and will vest as to 25% on January 14, 2027, with the remainder vesting in three equal annual installments thereafter, subject to the Reporting Person's continued service with the Company through the applicable vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the NuCana (NCNA) Form 3 for Jeffrey D. Bloss report?
The Form 3 reports Chief Medical Officer Jeffrey D. Bloss’s existing holdings in NuCana. It discloses several option awards over Ordinary Shares and a direct position of 47,136 Ordinary Shares, providing a baseline of his equity exposure as an executive.
Are there any buy or sell transactions in this NuCana (NCNA) Form 3?
No new buy or sell transactions are shown in this Form 3. The entries are classified as holdings, meaning the document records existing option and share positions rather than recent market trades or exercises that change Bloss’s ownership.
What option exercise prices are disclosed for NuCana (NCNA) Chief Medical Officer Bloss?
The filing shows options over NuCana Ordinary Shares with very low exercise prices. These options carry exercise prices of 0.0004, 0.0005, and 0.004 Pounds Sterling, indicating they are deeply in-the-money if the market price is materially higher than these nominal strike levels.
When do Jeffrey Bloss’s NuCana (NCNA) options vest according to the Form 3?
Some options were fully vested by June 20, 2025 and January 14, 2026. Other grants vest 25% on June 20, 2026 and January 14, 2027, with the remaining portions vesting in three equal annual installments, contingent on Bloss’s continued service with NuCana.
How long do the reported NuCana (NCNA) options for Jeffrey Bloss remain exercisable?
The Form 3 notes option expirations on June 20, 2035 and January 14, 2036 for certain grants. These long-dated expirations give Bloss an extended period to exercise vested options, aligning his incentives with NuCana’s long-term performance over many years.
What type of NuCana (NCNA) security does Jeffrey Bloss directly own?
In addition to options, Jeffrey Bloss directly owns NuCana Ordinary Shares. The filing reports direct ownership of 47,136 Ordinary Shares, separate from the underlying shares tied to his various option awards disclosed in the same Form 3.
AI-generated analysis. How Rhea-AI works. Not financial advice.
